AKT1 and colorectal carcinoma: Notably, when PI3K/AKT pathway inhibitor LY294002 was added, the expression of the above proteins was significantly reduced, further confirming that low expression of 2 could promote M2 polarization through PI3K/AKT pathway and further affect CRC.